Jia Mengmeng, Ji Guangquan, Wang Ruifang, Yan Zhen, Niu Wei, Chen Jian, Yu Juanjuan
Department of Obstetrics and Gynecology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, 471003, China.
Department of Neurosurgery, The Third Affiliated Hospital of Henan University of Science and Technology, Luoyang, 471003, China.
BMC Surg. 2025 Jul 3;25(1):266. doi: 10.1186/s12893-025-02981-y.
The objective of this study is to systematically evaluate the efficacy of Extraperitoneal Cesarean Section (ECS) compared to Transabdominal Cesarean Section (TCS) in pregnant women, and to assess the differences in treatment outcomes between the two surgical approaches.
We conducted an extensive literature search, pulling up the most recent findings from reputable sources like the Cochrane Library, PubMed, EMBASE, Google Scholar, and Web of Science, all the way up to October 2024. Our meta-analysis comprised seven randomized controlled trials. We followed a fixed-effects model for results with less heterogeneity and a random-effects model for those with more. We utilized Stata 18 to conduct data analysis. For continuous data, we computed weighted mean differences (WMD). For categorical data, we calculated odds ratios (OR). We also included 95% confidence intervals (CI) with all of our results. We also used the Cochrane Risk of Bias tool to check all of the randomized controlled trials (RCTs) for bias.
This meta-analysis did not find any statistically significant differences between the two groups when it came to baseline factors such as Body Mass Index (BMI), gestational week, and history of cesarean section. Statistical analysis revealed no significant differences in surgical outcomes (i.e., time to delivery(WMD 2.25, 95% CI -0.29 to 4.79, p = 0.083), time to operation (WMD 3.11, 95% CI -2.96 to 9.18, p = 0.316), neonatal weight (WMD -62.25, 95% CI -152.37 to 27.87, p = 0.176), 1-min Apgar score (WMD 0.03, 95% CI -0.39 to 0.45, p = 0.897), 5-min Apgar score (WMD 0.09, 95% CI -0.07 to 0.24, p = 0.296), blood loss (WMD 36.41, 95% CI -21.51 to 94.32, p = 0.218), etc.) between the TCS and ECS groups. However, the ECS group had a significantly shorter hospital stay (WMD -0.51, 95% CI -0.89 to -0.13, p=0.009) and less reduction in hemoglobin level (WMD -0.23, 95% CI -0.39 to -0.07, p=0.004) compared to TCS.
To sum up, this meta-analysis shows that ECS may help with postoperative hemoglobin level changes and shortening hospital stays. ECS may improve recovery metrics without adversely affecting maternal or neonatal outcomes. This analysis provides valuable insights that can guide clinical decision-making, even though there was no statistically significant difference between the two surgical approaches in terms of delivery time, operative time, neonatal weight, Apgar scores, or blood loss.
本研究的目的是系统评价腹膜外剖宫产术(ECS)与经腹剖宫产术(TCS)在孕妇中的疗效,并评估两种手术方式治疗结局的差异。
我们进行了广泛的文献检索,检索了截至2024年10月来自Cochrane图书馆、PubMed、EMBASE、谷歌学术和科学网等知名来源的最新研究结果。我们的荟萃分析纳入了7项随机对照试验。对于异质性较小的结果,我们采用固定效应模型;对于异质性较大的结果,我们采用随机效应模型。我们使用Stata 18进行数据分析。对于连续数据,我们计算加权平均差(WMD)。对于分类数据,我们计算比值比(OR)。我们还在所有结果中纳入了95%置信区间(CI)。我们还使用Cochrane偏倚风险工具检查所有随机对照试验(RCT)是否存在偏倚。
该荟萃分析发现,在体重指数(BMI)、孕周和剖宫产史等基线因素方面,两组之间没有任何统计学上的显著差异。统计分析显示,TCS组和ECS组在手术结局(即分娩时间(WMD 2.25,95%CI -0.29至4.79,p = 0.083)、手术时间(WMD 3.11,95%CI -2.96至9.18,p = 0.316)、新生儿体重(WMD -62.25,95%CI -152.37至27.87,p = 0.176)、1分钟阿氏评分(WMD 0.03,95%CI -0.39至0.45,p = 0.897)、5分钟阿氏评分(WMD 0.09,95%CI -0.07至0.24,p = 0.296)、失血量(WMD 36.41,95%CI -21.51至94.32,p = 0.218)等)方面没有显著差异。然而,与TCS相比,ECS组的住院时间明显更短(WMD -0.51,95%CI -0.89至-0.13,p = 0.009),血红蛋白水平下降更少(WMD -0.23,95%CI -0.39至-0.07,p = 0.004)。
综上所述,该荟萃分析表明,ECS可能有助于改善术后血红蛋白水平变化并缩短住院时间。ECS可能改善恢复指标,而不会对母婴结局产生不利影响。尽管在分娩时间、手术时间、新生儿体重、阿氏评分或失血量方面,两种手术方式没有统计学上的显著差异,但该分析提供了有价值的见解,可指导临床决策。